|
1
|
Chen L, Magliano DJ and Zimmet PZ: The
worldwide epidemiology of type 2 diabetes mellitus-present and
future perspectives. Nat Rev Endocrinol. 8:228–236. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kelly DJ, Gilbert RE, Cox AJ, Soulis T,
Jerums G and Cooper ME: Aminoguanidine ameliorates overexpression
of prosclerotic growth factors and collagen deposition in
experimental diabetic nephropathy. J Am Soc Nephrol. 12:2098–2107.
2001.PubMed/NCBI
|
|
3
|
Schmid H, Boucherot A, Yasuda Y, Henger A,
Brunner B, Eichinger F, Nitsche A, Kiss E, Bleich M, Gröne HJ, et
al: Modular activation of nuclear factor-kappaB transcriptional
programs in human diabetic nephropathy. Diabetes. 55:2993–3003.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Seckeler MD and Hoke TR: The worldwide
epidemiology of acute rheumatic fever and rheumatic heart disease.
Clin Epidemiol. 3:67–84. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Navarro JF, Mora C, Muros M and Garcia J:
Urinary tumour necrosis factor-alpha excretion independently
correlates with clinical markers of glomerular and
tubulointerstitial injury in type 2 diabetic patients. Nephrol Dial
Transplant. 21:3428–3434. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oldfield MD, Bach LA, Forbes JM,
Nikolic-Paterson D, McRobert A, Thallas V, Atkins RC, Osicka T,
Jerums G and Cooper ME: Advanced glycation end products cause
epithelial-myofibroblast transdifferentiation via the receptor for
advanced glycation end products (RAGE). J Clin Invest.
108:1853–1863. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gilbert RE and Cooper ME: The
tubulointerstitium in progressive diabetic kidney disease: More
than an aftermath of glomerular injury? Kidney Int. 56:1627–1637.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fioretto P and Mauer M: Histopathology of
diabetic nephropathy. Semin Nephrol. 27:195–207. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lam S, van der Geest RN, Verhagen NA, van
Nieuwenhoven FA, Blom IE, Aten J, Goldschmeding R, Daha MR and van
Kooten C: Connective tissue growth factor and igf-I are produced by
human renal fibroblasts and cooperate in the induction of collagen
production by high glucose. Diabetes. 52:2975–2983. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wada T, Furuichi K, Sakai N, Iwata Y,
Yoshimoto K, Shimizu M, Takeda SI, Takasawa K, Yoshimura M, Kida H,
et al: Up-regulation of monocyte chemoattractant protein-1 in
tubulointerstitial lesions of human diabetic nephropathy. Kidney
Int. 58:1492–1499. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang C, Shen S, Ma Q, Gill A, Pollock CA
and Chen XM: KCa3.1 mediates activation of fibroblasts in diabetic
renal interstitial fibrosis. Nephrol Dial Transplant. 29:313–324.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Simonson MS: Phenotypic transitions and
fibrosis in diabetic nephropathy. Kidney Int. 71:846–854. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kalluri R and Neilson EG:
Epithelial-mesenchymal transition and its implications for
fibrosis. J Clin Invest. 112:1776–1784. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sharma K and Ziyadeh FN: Hyperglycemia and
diabetic kidney disease. The case for transforming growth
factor-beta as a key mediator. Diabetes. 44:1139–1146. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pankewycz OG, Guan JX, Bolton WK, Gomez A
and Benedict JF: Renal TGF-beta regulation in spontaneously
diabetic NOD mice with correlations in mesangial cells. Kidney Int.
46:748–758. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han DC, Isono M, Hoffman BB and Ziyadeh
FN: High glucose stimulates proliferation and collagen type I
synthesis in renal cortical fibroblasts: Mediation by autocrine
activation of TGF-beta. J Am Soc Nephrol. 10:1891–1899.
1999.PubMed/NCBI
|
|
17
|
Hong SW, Isono M, Chen S, Iglesias-De La
Cruz MC, Han DC and Ziyadeh FN: Increased glomerular and tubular
expression of transforming growth factor-beta1, its type II
receptor and activation of the Smad signaling pathway in the db/db
mouse. Am J Pathol. 158:1653–1663. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sharma K, Jin Y, Guo J and Ziyadeh FN:
Neutralization of TGF-beta by anti-TGF-beta antibody attenuates
kidney hypertrophy and the enhanced extracellular matrix gene
expression in STZ-induced diabetic mice. Diabetes. 45:522–530.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kato M, Yuan H, Xu ZG, Lanting L, Li SL,
Wang M, Hu MC, Reddy MA and Natarajan R: Role of the Akt/FoxO3a
pathway in TGF-beta1-mediated mesangial cell dysfunction: A novel
mechanism related to diabetic kidney disease. J Am Soc Nephrol.
17:3325–3335. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang M, Fraser D and Phillips A: ERK, p38
and Smad signaling pathways differentially regulate transforming
growth factor-beta1 autoinduction in proximal tubular epithelial
cells. Am J Pathol. 169:1282–1293. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tomat AL, Costa MA, Girgulsky LC, Veiras
L, Weisstaub AR, Inserra F, Balaszczuk AM and Arranz CT: Zinc
deficiency during growth: Influence on renal function and
morphology. Life Sci. 80:1292–1302. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hagmeyer S, Haderspeck JC and Grabrucker
AM: Behavioral impairments in animal models for zinc deficiency.
Front Behav Neurosci. 8:4432015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Salgueiro MJ, Krebs N, Zubillaga MB, Weill
R, Postaire E, Lysionek AE, Caro RA, De Paoli T, Hager A and Boccio
J: Zinc and diabetes mellitus: Is there a need of zinc
supplementation in diabetes mellitus patients? Biol Trace Elem Res.
81:215–228. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Batista MN, Cuppari L, de Fátima Campos
Pedrosa L, Almeida Md, de Almeida JB, de Medeiros AC and Canziani
ME: Effect of end-stage renal disease and diabetes on zinc and
copper status. Biol Trace Elem Res. 112:1–12. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ozcelik D, Tuncdemir M, Ozturk M and Uzun
H: Evaluation of trace elements and oxidative stress levels in the
liver and kidney of streptozotocin-induced experimental diabetic
rat model. Gen Physiol Biophys. 30:356–363. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Parham M, Amini M, Aminorroaya A and
Heidarian E: Effect of zinc supplementation on microalbuminuria in
patients with type 2 diabetes: A double blind, randomized,
placebo-controlled, cross-over trial. Rev Diabet Stud. 5:102–109.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Al-Timimi DJ, Sulieman DM and Hussen KR:
Zinc status in type 2 diabetic patients: Relation to the
progression of diabetic nephropathy. J Clin Diagn Res. 8:CC04–CC08.
2014.PubMed/NCBI
|
|
28
|
Takahashi M, Saito H, Higashimoto M and
Hibi T: Possible inhibitory effect of oral zinc supplementation on
hepatic fibrosis through downregulation of TIMP-1: A pilot study.
Hepatol Res. 37:405–409. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gandhi MS, Deshmukh PA, Kamalov G, Zhao T,
Zhao W, Whaley JT, Tichy JR, Bhattacharya SK, Ahokas RA, Sun Y, et
al: Causes and consequences of zinc dyshomeostasis in rats with
chronic aldosteronism. J Cardiovasc Pharmacol. 52:245–252. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Van Biervliet S, Velde S Vande, Van
Biervliet JP and Robberecht E: The effect of zinc supplements in
cystic fibrosis patients. Ann Nutr Metab. 52:152–156. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang X, Wang J, Fan Y, Yang L, Wang L and
Ma J: Zinc supplementation attenuates high glucose-induced
epithelial-to-mesenchymal transition of peritoneal mesothelial
cells. Biol Trace Elem Res. 150:229–235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tesch GH and Allen TJ: Rodent models of
streptozotocin-induced diabetic nephropathy. Nephrology (Carlton).
12:261–266. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang X, Liang D, Chi ZH, Chu Q, Zhao C,
Ma RZ, Zhao Y and Li H: Effect of zinc on high glucose-induced
epithelial-to-mesenchymal transition in renal tubular epithelial
cells. Int J Mol Med. 35:1747–1754. 2015.PubMed/NCBI
|
|
34
|
Pories WJ, DeWys WD, Flynn A, Mansour EG
and Strain WH: Implications of the inhibition of animal tumors by
dietary zinc deficiency. Adv Exp Med Biol. 91:243–257. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang S, Denichilo M, Brubaker C and
Hirschberg R: Connective tissue growth factor in tubulointerstitial
injury of diabetic nephropathy. Kidney Int. 60:96–105. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kelly DJ, Chanty A, Gow RM, Zhang Y and
Gilbert RE: Protein kinase Cbeta inhibition attenuates osteopontin
expression, macrophage recruitment and tubulointerstitial injury in
advanced experimental diabetic nephropathy. J Am Soc Nephrol.
16:1654–1660. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gilbert RE, Cox A, Wu LL, Allen TJ,
Hulthen UL, Jerums G and Cooper ME: Expression of transforming
growth factor-beta1 and type IV collagen in the renal
tubulointerstitium in experimental diabetes: Effects of ACE
inhibition. Diabetes. 47:414–422. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nawar O, Akridge RE, Hassan E, el Gazar R,
Doughty BL and Kemp WM: The effect of zinc deficiency on granuloma
formation, liver fibrosis and antibody responses in experimental
schistosomiasis. Am J Trop Med Hyg. 47:383–389. 1992.PubMed/NCBI
|
|
39
|
Gomot MJ, Faure P, Roussel AM, Coudray C,
Osman M and Favier A: Effect of acute zinc deficiency on insulin
receptor binding in rat adipocytes. Biol Trace Elem Res.
32:331–335. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zalewski PD: Zinc metabolism in the
airway: Basic mechanisms and drug targets. Curr Opin Pharmacol.
6:237–243. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Szuster-Ciesielska A, Plewka K, Daniluk J
and Kandefer-Szerszeń M: Zinc supplementation attenuates ethanol-
and acetaldehyde-induced liver stellate cell activation by
inhibiting reactive oxygen species (ROS) production and by
influencing intracellular signaling. Biochem Pharmacol. 78:301–314.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Burns WC, Twigg SM, Forbes JM, Pete J,
Tikellis C, Thallas-Bonke V, Thomas MC, Cooper ME and Kantharidis
P: Connective tissue growth factor plays an important role in
advanced glycation end product-induced tubular
epithelial-to-mesenchymal transition: Implications for diabetic
renal disease. J Am Soc Nephrol. 17:2484–2494. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tang Y, Yang Q, Lu J, Zhang X, Suen D, Tan
Y, Jin L, Xiao J, Xie R, Rane M, et al: Zinc supplementation
partially prevents renal pathological changes in diabetic rats. J
Nutr Biochem. 21:237–246. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Özcelik D, Naziroglu M, Tuncdemir M, Celik
Ö, Öztürk M and Flores-Arce MF: Zinc supplementation attenuates
metallothionein and oxidative stress changes in kidney of
streptozotocin-induced diabetic rats. Biol Trace Elem Res.
150:342–349. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hills CE, Al-Rasheed N, Willars GB and
Brunskill NJ: C-peptide reverses TGF-beta1-induced changes in renal
proximal tubular cells: Implications for treatment of diabetic
nephropathy. Am J Physiol Renal Physiol. 296:F614–F621. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu Y: New insights into
epithelial-mesenchymal transition in kidney fibrosis. J Am Soc
Nephrol. 21:212–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wolf G and Ziyadeh FN: Molecular
mechanisms of diabetic renal hypertrophy. Kidney Int. 56:393–405.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lv ZM, Wang Q, Wan Q, Lin JG, Hu MS, Liu
YX and Wang R: The role of the p38 MAPK signaling pathway in high
glucose-induced epithelial-mesenchymal transition of cultured human
renal tubular epithelial cells. PLoS One. 6:e228062011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mason RM and Wahab NA: Extracellular
matrix metabolism in diabetic nephropathy. J Am Soc Nephrol.
14:1358–1373. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Corniola RS, Tassabehji NM, Hare J, Sharma
G and Levenson CW: Zinc deficiency impairs neuronal precursor cell
proliferation and induces apoptosis via p53-mediated mechanisms.
Brain Res. 1237:52–61. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yamaguchi M and Kishi S: Differential
effects of transforming growth factor-beta on osteoclast-like cell
formation in mouse marrow culture: Relation to the effect of
zinc-chelating dipeptides. Peptides. 16:1483–1488. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Du Y, Guo D, Wu Q, Liu D and Bi H: Zinc
chloride inhibits human lens epithelial cell migration and
proliferation involved in TGF-β1 and TNF-α signaling pathways in
HLE B-3 cells. Biol Trace Elem Res. 159:425–433. 2014. View Article : Google Scholar : PubMed/NCBI
|
